TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients-Reference-Cited by-同舟云学术

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients

Published:2016-05-11 Issue: Volume:07 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Halvorsen Ann R.,Silwal-Pandit Laxmi,Meza-Zepeda Leonardo A.,Vodak Daniel,Vu Phuong,Sagerup Camilla,Hovig Eivind,Myklebost Ola,Børresen-Dale Anne-Lise,Brustugun Odd T.,Helland Åslaug

Publisher

Frontiers Media SA

Subject

Genetics(clinical),Genetics,Molecular Medicine

Reference31 articles.

1. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.;Bougeard;J. Med. Genet.,2008

2. Comprehensive genomic characterization of squamous cell lung cancers.;Cancer Genome Atlas Research Network;Nature,2012

3. Comprehensive molecular profiling of lung adenocarcinoma.;Cancer Genome Atlas Research Network;Nature,2014

4. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.;Cibulskis;Nat. Biotechnol.,2013

5. Somatic mutations affect key pathways in lung adenocarcinoma.;Ding;Nature,2008

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study;Frontiers in Oncology;2024-07-09

2. Molecular mechanism of radiation tolerance in lung adenocarcinoma cells using single‐cell RNA sequencing;Journal of Cellular and Molecular Medicine;2024-05

3. Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample;Scientific Reports;2024-03-16

4. Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma;International Journal of Cancer;2024-03-15

5. Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non–Small-Cell Lung Cancer;JCO Precision Oncology;2024-02